Designing a Review-Ready Exhibit Program for PRC and FDA Requirements

The Scenario

Novara Medical Technologies is a fictional MedTech company developing advanced clinical technologies for hospital and specialist-care environments. As its conference presence grows, the company needs exhibit programs that can support product education, stakeholder review, and compliant message control.

The Challenge

Novara Medical Technologies was preparing for a high-value healthcare conference season. The company had strong product momentum, a growing sales team, and a clear need for a more professional congress presence.

But the exhibit program had become difficult to manage.

Every new booth graphic, product claim, digital screen, literature piece, and layout adjustment created another layer of review. Internal teams needed to confirm what was approved, what had changed, what required review, and how each element would appear in the physical booth.

The stakes were significant. Freeman’s 2024 Attendee Intent and Behavior research found that 92% of respondents expected to attend more in-person events in 2024 than in 2023, while 80% viewed in-person events as the most trusted marketing channel. For Novara, the booth could not be treated as a last-minute production task. It was a key environment for product education, relationship building, and stakeholder confidence.

Healthcare exhibit teams also operate under additional pressure. Booth graphics, product messaging, digital content, literature, demonstrations, and safety information all require review before they appear publicly. If those components are developed without a clear review structure, even minor revisions can create late-stage delays.

Novara’s existing approach created several pain points:

• Booth graphics were reviewed separately from the full booth layout
• Product claims were difficult to track once placed into the exhibit environment
• Literature locations were not always documented early enough
• Late feedback created expensive revisions close to show dates
• The team lacked a clean process for updating approved materials across multiple events
• Stakeholders and reviewers needed a clearer view of how booth components, messaging, and claims worked together to maintain fair balance and compliance

Novara needed more than a booth design. They needed a review-ready exhibit system.

The Exhibit Strategy

Instead of beginning with visual design alone, the team mapped the exhibit as a system of reviewable components. The booth was organized around defined content zones, including product education, demonstration space, literature placement, digital content, meeting areas, and safety or compliance information where applicable.

This approach gave Novara a clearer way to evaluate not only what each component said, but where and how it would appear in the attendee experience.

By using a custom-rental model, this allowed Novara to maintain a polished, brand-right environment while keeping the architecture flexible enough to accommodate late-stage review feedback.

Building for PRC Review  

The exhibit was planned with internal review teams in mind from the start.

Each graphic, screen, demo area, and literature zone was treated as a distinct component. The booth layout was designed so reviewers could understand where each message would appear, how attendees would encounter it, and what supporting materials would be available nearby.

This was important because review requirements often extend beyond the individual graphic or message. In regulated healthcare environments, the context of placement, proximity, hierarchy, and supporting materials can matter just as much as the content itself.

For teams working with prescription drug promotional materials, FDA submission processes require discipline around materials, claims, and supporting references. According to the FDA’s advertising and promotional labeling Q&A, final promotional materials for prescription drug products must be submitted with Form FDA 2253 at the time of initial dissemination of labeling or initial publication of an advertisement.

Although Novara is a fictional MedTech company, the principle still applies: the exhibit needed to make review easier before production began.

That meant building the booth around clear documentation, including annotated schematics, defined material locations, content zones, and literature placement. Instead of reviewing isolated assets without context, stakeholders could see how the complete booth experience worked together.

 Managing Change Without Starting Over  

Novara’s team knew change was likely.

Reviewers could request softer language, revised hierarchy, updated visuals, adjusted literature placement, or additional context for product demonstrations. Digital content might need more time in review than static graphics. Certain claims might need to be revised, relocated, or removed.

The custom-rental model gave Novara the ability to respond without rebuilding the entire booth.

Graphic panels could be replaced. Digital content zones could be updated. Literature areas could be adjusted. Demonstration spaces could be refined. Messaging could be revised while the overall exhibit footprint, structure, storage, and traffic flow remained intact.

The booth was not fragile. It was built to change.

This flexibility mattered because in-person events remain an important discovery channel. Freeman’s attendee research found that 87% of respondents named discovering new products, solutions, and partners as a top factor influencing attendance. Novara needed to show up with a strong product education experience, but not at the expense of review discipline.

Why the Custom-Rental Access Model Made Sense 

For Novara, owning a fully custom exhibit would have created unnecessary risk.

The team’s messaging, review needs, product priorities, and conference strategy were still evolving. A rigid owned structure could have locked the company into decisions that might not survive legal, regulatory, medical, or stakeholder review.

The custom-rental model gave Novara access to a high-quality exhibit presence without the burden of permanent ownership. More importantly, it gave the team a structure that could adapt as review requirements changed.

That adaptability was especially valuable in a regulated environment where even small content changes can affect timelines, approvals, and production.

Rather than treating the booth as a finished object, Novara treated it as a flexible system: one that could support approved product education today and evolve with future conference needs, messaging updates, and reviewer feedback.

The Strategic Value

The value of the custom-rental model was not just flexibility in the build. It was flexibility in the review process.

Novara could keep the core architecture consistent while changing the elements most likely to be affected by stakeholder feedback: graphics, messaging, digital content, product demonstration details, literature placement, and compliance information.

That approach helped the team reduce ambiguity, avoid unnecessary rebuilds, and give reviewers a clearer view of the full attendee experience.

It also helped marketing, sales, regulatory, and medical stakeholders work from the same source of truth. Everyone could see how the booth was structured, where each message appeared, and how changes could be made without disrupting the entire exhibit program.

The Outcome

Novara entered its conference season with a booth program that was easier to review, easier to revise, and easier to scale.

The team had a clearer process for connecting exhibit design to internal approval. Reviewers could evaluate content in context. Marketing could move forward with greater confidence. And production teams had fewer late-stage surprises because the exhibit had been planned for change from the beginning.

The final booth felt polished and intentional on the show floor, but behind the scenes it functioned as a flexible, review-ready system.